MYCT1は,ヒトの造血幹細胞における環境感知を制御する

Júlia Aguadé-Gorgorió^1,2, Yasaman Jami-Alahmadi^3,4, Vincenzo Calvanese^5,6,7,8

¹Department of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, CA, USA. julia.aguade@gmail.com.

Nature

|June 5, 2024

まとめ

MYCターゲット1 (MYCT1) は,ヒト造血幹細胞 (HSC) の自己再生を抑制して制御する. MYCT1を復元すると,幹の保存に不可欠なHSCの拡張と移植が改善されます.

科学分野:

血液学
幹細胞生物学
分子生物学

背景:

人間の造血幹細胞 (HSC) の自己再生と移植は十分に理解されず,培養で複製することが困難である.
現在の方法は,治療用途の機能的なHSCを確実に拡張するのに苦労しています.

研究の目的:

ヒトのHSCの自己更新と移植の重要なレギュラーを特定する.
MYC target 1 (MYCT1) が,培養中にHSCの茎性を維持する役割を調査する.

主な方法:

ヒト胎児の肝臓および帯血 (CB) の血液生成幹細胞および祖先細胞 (HSPCs) のレンチウイルス媒介のノックダウンおよび過剰発現.
遺伝子発現の変化を分析するための単細胞RNA配列解析
HSPCの膨張,移植,内細胞化率,ミトコンドリアの活性を評価する検査です.

主要な成果:

MYCT1は分化されていないHSPCで選択的に発現し,培養中にダウンレギュレーションされます.
MYCT1のノックダウンにより HSPCの拡張と移植が妨げられました.
MYCT1発現を回復させることで,培養CB HSPCの拡張と移植が強化された.
MYCT1は,ETS因子の発現,ミトコンドリアの活性,内細胞化を調節し,HSCの幹性を保ちます.

結論:

MYCT1はヒトのHSC幹の重要な調節体であり,内細胞化と環境感知を抑制する.
培養中のMYCT1のダウンレギュレーションは,HSCの拡大を危うくする脆弱性です.
MYCT1をターゲットにすることで,HSCの拡張と治療的応用を改善する戦略が提供されます.

さらに関連する動画

08:34

Flow Cytometry Analysis of Murine Bone Marrow Hematopoietic Stem and Progenitor Cells and Stromal Niche Cells

Published on: September 28, 2022

4.1K

11:06

Combining Intravital Fluorescent Microscopy IVFM with Genetic Models to Study Engraftment Dynamics of Hematopoietic Cells to Bone Marrow Niches

Published on: March 21, 2017

7.9K

関連する概念動画

01:01

Regulation of Hematopoietic Stem Cells

3.2K

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

3.2K

01:19

Multipotency of Hematopoietic Stem Cells

3.1K

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

3.1K

01:21

Lineage Commitment

3.0K

Commitment is the process whereby stem cells:

3.0K

01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

2.1K

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

2.1K

01:21

Hematopoiesis

5.2K

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...